Amphastar Pharmaceuticals (AMPH) Curent Deferred Tax Liability (2014 - 2015)

Amphastar Pharmaceuticals (AMPH) recorded quarterly Curent Deferred Tax Liability of $161000.0 in Q3 2015, up 1.26% quarter-over-quarter from $159000.0 in Q2 2015, and down 79.8% on a YoY basis from $797000.0 in Q3 2014.

Amphastar Pharmaceuticals (AMPH) Curent Deferred Tax Liability (2014 - 2015) Analysis & Trends

Amphastar Pharmaceuticals' Curent Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $161000.0 for Q3 2015.

  • In Q3 2015, Curent Deferred Tax Liability fell 79.8% year-over-year to $161000.0; the TTM figure through Sep 2015 stood at $161000.0 (down 79.8% YoY), while the FY2014 annual figure was $1.2 million, changed N/A from the prior year.
  • Curent Deferred Tax Liability was $161000.0 for Q3 2015 at Amphastar Pharmaceuticals, up from $159000.0 in the prior quarter.
  • In the past five years, Curent Deferred Tax Liability ranged from a high of $1.2 million in Q4 2014 to a low of $156000.0 in Q1 2015.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Amphastar Pharmaceuticals 914.14 Mn 914.14 Mn 70.32 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2015 161,000.00
Sep 30, 2015 161,000.00
Jun 30, 2015 159,000.00
Jun 30, 2015 159,000.00
Mar 31, 2015 156,000.00
Mar 31, 2015 156,000.00
Dec 31, 2014 1.19 Mn
Dec 31, 2014 1.19 Mn
Sep 30, 2014 797,000.00
Sep 30, 2014 797,000.00